Search

Displaying results 4851 - 4860 of 7604 in total
  1. Drug

    SRP-9005

    go.drugbank.com/drugs/DB17958
    Investigational

    Developed by the Kurt+Peter Foundation and Sarepta Therapeutics, it is being investigated for the treatment of Limb-girdle muscular dystrophy (LGMD) type 2C/R5.[A260142]

  2. Drug

    Terdecamycin

    go.drugbank.com/drugs/DB19720
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Terdecamycin is a antibiotic, produced by Streptomyces strain. Terdecamycin has a monoisotopic molecular weight of 585.31 Da.

  3. Drug

    Stallimycin

    go.drugbank.com/drugs/DB20261
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Stallimycin is a antibiotic, produced by Streptomyces strain. Stallimycin has a monoisotopic molecular weight of 481.22 Da.

  4. Drug

    Steffimycin

    go.drugbank.com/drugs/DB19922
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Steffimycin is a antibiotic, produced by Streptomyces strain. Steffimycin has a monoisotopic molecular weight of 574.17 Da.

  5. Drug

    Anthelmycin

    go.drugbank.com/drugs/DB20238
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Anthelmycin is a antibiotic, produced by Streptomyces strain. Anthelmycin has a monoisotopic molecular weight of 583.23 Da.

  6. Drug

    Bluensomycin

    go.drugbank.com/drugs/DB20923
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Bluensomycin is a antibiotic, produced by Streptomyces strain. Bluensomycin has a monoisotopic molecular weight of 585.25 Da.

  7. Drug

    Lydimycin

    go.drugbank.com/drugs/DB21235
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Lydimycin is a antibiotic, produced by Streptomyces strain. Lydimycin has a monoisotopic molecular weight of 242.07 Da.

  8. Drug

    13-deoxydoxorubicin

    go.drugbank.com/drugs/DB05706
    Investigational

    GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.

  9. Drug

    Azelnidipine

    go.drugbank.com/drugs/DB09230
    Investigational

    It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan.

  10. Drug

    Selisistat

    go.drugbank.com/drugs/DB13978
    Investigational

    Selective inhibitor of SIRT1 that does not inhibit histone deacetylase (HDAC) or other sirtuin deacetylase family members (IC50 values are 98, 19600, 48700, > 100000 and > 100000 nM for SIRT1, SIRT2, SIRT3 … Enhances p53 acetylation in response to DNA damaging agents.